You eat less food, which means less fluid from food
In clinical trials, participants lost approximately 15% of their body weight at the 5 mg dose and about 20% at the 15 mg dose over 72 weeks in the SURMOUNT-1 trial
The third target, glucagon receptors, is what makes Retatrutide stand apart from most other weight loss peptides
Comparing Semaglutide to Tirzepatide Results If youre deciding between weight loss medications, comparing semaglutide results to tirzepatide (another GLP-1 medication) provides helpful context
Shares of Hims & Hers were little changed on the news, adding 0.6% at about $24, while Novo Nordisk shares fell 6.5% to about $44.
Long-term success means building new habits, honoring your changing appetite, and fueling your body with intention